Filing Details
- Accession Number:
- 0001213900-20-029901
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-02 16:02:46
- Reporting Period:
- 2020-10-01
- Accepted Time:
- 2020-10-02 16:02:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1553643 | Relmada Therapeutics Inc. | RLMD | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1117167 | J Charles Casamento | C/O Relmada Therapeutics, Inc. 880 Third Avenue, 12Th Floor New York NY 10022 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-10-01 | 3,000 | $37.99 | 52,173 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020. The range of prices for the transaction reported on this line was $37.04 to $38.58. The average weighted price was $37.9852. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
